Neuro-Oncology for the Clinical Neurologist
Original price was: $190.73.$112.19Current price is: $112.19.
Neuro-Oncology for the Clinical Neurologist | 9780323694940, Elsevier, Roy E., Strowd
Author: Strowd, Roy E.
Brand: Elsevier
Edition: 1
ISBN: 9780323694940
Release Date: 18-12-2020
Package Dimensions: 9.3 x 7.6 x 0.9 inches
Languages: English
Binding: Hardcover
Number Of Pages: 448
Details: In the growing field of neuro-oncology, the past few years have witnessed rapid advances in tumor classification, treatment modalities, and the role of neurologists and neuro-oncologists. Neuro-Oncology for the Clinical Neurologist is a first-of-its-kind resource that focuses on patient-clinical scenarios relevant to the practicing neurologist―bringing you up to date with everything from basic principles and neuro-oncology imaging consults to neurologic complications of radiation, systemic, and immune-based therapies, and much more. Focuses on the clinical management of patients typically encountered by neurologists and neurology trainees. Provides clinically relevant updates in five key areas of neuro-oncology: primary CNS tumors, brain and leptomeningeal metastases, inherited tumor syndromes of the nervous system (e.g. neurofibromatosis), paraneoplastic and immune-mediated neurological complications of cancer, and neurological complications of cancer treatments. Includes a summary of clinical pearls and a reference list of clinical cases. Anchors each chapter with patient cases and clinical scenarios, provides evidence-based discussion, and explains patient management. Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
User Reviews
Be the first to review “Neuro-Oncology for the Clinical Neurologist”
Vendor Information
- Store Name: Adobooks Marketplace
- Vendor: Adobooks Marketplace
- No ratings found yet!
Product Enquiry
Original price was: $190.73.$112.19Current price is: $112.19.


There are no reviews yet.